Guilin Fuda Co.,Ltd.(603166.SH)'s application for issuing convertible bonds to unspecified objects accepted by the Shanghai Stock Exchange.
Fuda Co., Ltd. (603166.SH) announced that on October 8, 2026, the company received a "Notice on Accepting the Application of Guilin Fuda Co., Ltd., a Shanghai Stock Exchange Main Board Listed Company, for Issuing Securities" issued by the Shanghai Stock Exchange (the "SSE"). In accordance with relevant regulations, the SSE reviewed the prospectus and related application documents submitted by the company for the issuance of securities by a Shanghai Stock Exchange Main Board listed company, determined that the application documents are complete and comply with statutory form requirements, and decided to accept the application and conduct review in accordance with the law.
Guilin Fuda Co.,Ltd. (603166.SH) announced that on October 8, 2026, the company received a "Notice on Accepting the Application for Securities Issuance by a Company Listed on the Main Board of the Shanghai Stock Exchange" issued by the Shanghai Stock Exchange (the "SSE"). In accordance with relevant regulations, the SSE reviewed the prospectus and related application documents submitted by the company for securities issuance as a company listed on the SSE Main Board, determined that the application documents are complete and comply with statutory form requirements, and decided to accept the application and conduct review in accordance with the law.
Related Articles
EPS HEALTH TECH (03860): Cai Guanming Resigns as Independent Non-Executive Director
Tasly Pharmaceutical Group (600535.SH) subsidiary receives drug registration certificate for indocyanine green for injection.
CGN NEW ENERGY (01811) repurchased 740,000 shares for HK$1.5805 million on October 9.
EPS HEALTH TECH (03860): Cai Guanming Resigns as Independent Non-Executive Director
Tasly Pharmaceutical Group (600535.SH) subsidiary receives drug registration certificate for indocyanine green for injection.
CGN NEW ENERGY (01811) repurchased 740,000 shares for HK$1.5805 million on October 9.
